Coronary interventions

Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry

EuroIntervention 2016;11:1106-1110 published online ahead of print March 2015. DOI: 10.4244/EIJY15M03_08

Johannes Waltenberger
Johannes Waltenberger1*, MD; Johannes Brachmann2, MD, PhD; Jan van der Heyden3, MD, PhD; Gert Richardt4, MD, PhD; Ole Fröbert5, MD, PhD; Markus Seige6, MD; Andrejs Erglis7, MD, PhD; Willem Dewilde8, MD; Mark Winkens8, MD; Christian Hegeler-Molkewehrum9, MD; Norbert Klein10, MD; Stefan Hoffmann11, MD; for the BIOFLOW-III Investigators
1. Department of Cardiovascular Medicine, Universitätsklinikum Münster, Münster, Germany; 2. II. Medizinische Klinik, Klinikum Coburg, Coburg, Germany; 3. Department of Cardiology, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands; 4. Department of Car

Aims: We aimed to assess the safety and performance of a novel sirolimus-eluting stent with biodegradable polymer under real-world conditions.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

biodegradable polymerbioresorbable stentcoronary artery diseaseclinical researchpllasirolimus
Coronary interventionsStents and scaffoldsTools, devices and techniques
Read next article
Coronary microvascular function in patients with type 2 diabetes mellitus

Latest news